CLADE will be attending the Drug Delivery & Formulation Summit (DDF) Boston on 14–15 September 2026. We invite you to meet the CLADE team at booth 44 to discover how our...

We’re pleased to announce the launch of the new CLADE website, designed to make it easier for visitors to learn about CLADE solutions for biopharma bioanalytics, browse product information,...

CLADE will be attending the Bioprocessing Summit Boston from 10–13th August 2026. This event provides an excellent opportunity to meet with the global bioprocess experts that are driving innovation and productivity in...

We have released a new application note demonstrating how CLADETM Technologies can be used to rapidly detect and quantify sorbitol adulteration by ethylene glycol (EG) and diethylene glycol (DEG). The study presents the feasibility study for this application in...

CLADE is pleased to announce the start of a new distribution partnership agreement with Guangdong Denley Technology Co., Ltd., making CLADE’s bioanalytics products available to customers in the Chinese market through DenLey’s established...

CLADE is providing advanced bioanalytics tools for biologics development and QC which enable biopharma organisations to simplify their analytical workflows and make them more efficient. In addition to the...

CLADE took part in the Laboratories of the Future meeting in Paris this week, joining discussions on how automation, digitalisation and data-driven workflows are shaping the next generation of...

CLADE will be attending BIO International Convention 2026 in San Diego from 22–25 June. We invite you to meet the CLADE team at the German Pavilion, booth 3335, to...

CLADE is delighted to share a new addition to the leadership team.  Vinay brings deep expertise in mathematical modelling and data science, with a track record of building and deploying solutions that support biopharma workflows across R&D,...

Meet CLADE at the leading summit on drug delivery, formulation, and device development in Berlin on 18 – 20th May 2026.  You can learn about our multi-attribute, high-throughput analytics solution for biologics development and...